Filing Details
- Accession Number:
- 0001209191-15-052371
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-11 17:29:05
- Reporting Period:
- 2015-06-10
- Filing Date:
- 2015-06-11
- Accepted Time:
- 2015-06-11 17:29:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1393434 | Ocular Therapeutix Inc | OCUL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1367381 | Sv Life Sciences Fund Iv, L.p. | One Boston Place 201 Washington Street, Suite 3900 Boston MA 02108 | No | No | Yes | No | |
1392309 | Sv Life Sciences Fund Iv Strategic Partners, L. P. | One Boston Place 201 Washington Street, Suite 3900 Boston MA 02108 | No | No | Yes | No | |
1422339 | Svlsf Iv, Llc | One Boston Place 201 Washington Street, Suite 3900 Boston MA 02108 | No | No | Yes | No | |
1422340 | Sv Life Sciences Fund Iv (Gp), L.p. | One Boston Place 201 Washington Street, Suite 3900 Boston MA 02108 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-06-10 | 373,000 | $22.00 | 2,212,607 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2015-06-10 | 373,000 | $22.00 | 2,212,607 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2015-06-10 | 362,703 | $22.00 | 2,151,523 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-10 | 10,297 | $22.00 | 61,084 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares are owned directly by SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners"). SV Life Sciences Fund IV (GP), L.P. ("SVLS IV GP"), the general partner of SVLS IV LP and Strategic Partners, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLS IV GP disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest therein.
- These shares are owned directly by SVLS IV LP and Strategic Partners. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLSF IV, LLC disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest therein.
- These shares are held directly by SVLS IV LP.
- These shares are held directly by Strategic Partners.
- SVLS IV LP and Strategic Partners (each a "Fund", or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein.